Melanoma after the biopsy: Breslow, staging and follow-up
- Topic
Once a melanoma is confirmed, its depth in millimetres tells most of the story. Staging and follow-up are built on that number.
See it in 3D: Skin
What it is
Melanoma staging uses the American Joint Committee on Cancer (AJCC) TNM system, currently its 8th edition. T is set by Breslow thickness (in millimetres, from the top of the granular layer to the deepest tumour cell) and by ulceration; N by the number of involved lymph nodes and by satellite, microsatellite or in-transit metastases; M by the site of distant metastasis and the blood lactate dehydrogenase (LDH). Stages I and II are localised, stage III regional and stage IV distant. Sentinel lymph node biopsy stages the regional nodes in clinically node-negative patients. Follow-up looks for recurrence and for new primary melanomas, for life.
Key facts
- Breslow thickness is the most important prognostic factor in localised melanoma; diameter is not.
- Ulceration (loss of the epidermis over the tumour, seen under the microscope) upgrades every T category from «a» to «b».
- In the 8th edition, Clark level and mitotic rate are no longer used to set the T category, although the mitotic rate is still reported.
- Sentinel lymph node biopsy: a tracer is injected at the melanoma site to find the first draining node, which is removed and examined. It is generally discussed from T1b (0.8 mm or thicker, or ulcerated) upwards; its result is the strongest prognostic factor in these patients.
- Wide local excision follows the diagnostic biopsy; the margin grows with Breslow thickness, from about half a centimetre for melanoma in situ to two centimetres for thick tumours.
- Stage III and IV melanoma are treated by oncology with immunotherapy (anti-PD-1 and anti-CTLA-4 antibodies) or, if the tumour carries a BRAF V600 mutation, BRAF and MEK inhibitors, which have changed survival.
- People with one melanoma have a higher risk of a second primary melanoma; first-degree relatives also have higher risk.
Step by step
- Remove the suspicious lesion whole with a narrow margin, so the pathologist can measure the full depth.
- Read the pathology report: Breslow thickness, ulceration, mitotic rate, margins, subtype, microsatellites.
- Examine the scar area, the skin between it and the draining nodes, and the node basin.
- Assign the T category from thickness and ulceration; discuss sentinel node biopsy from T1b.
- Perform wide local excision with the margin set by thickness, ideally with the sentinel node biopsy.
- Stage the patient (I–IV); image only stage IIB and above, or anyone with symptoms.
- Plan follow-up by stage: skin and node checks for life, more often in the first years.
T category of melanoma (AJCC 8th edition)
| T category | Breslow thickness | «a» or «b» | Sentinel node biopsy |
|---|---|---|---|
| Tis (in situ) | Confined to the epidermis | Not applicable | Not indicated |
| T1a | Less than 0.8 mm, not ulcerated | a = no ulceration | Usually not indicated |
| T1b | Less than 0.8 mm ulcerated, or 0.8–1.0 mm | b = ulceration (or 0.8–1.0 mm) | Discussed with the patient |
| T2 | More than 1.0 to 2.0 mm | a = no ulceration, b = ulceration | Recommended |
| T3 | More than 2.0 to 4.0 mm | a = no ulceration, b = ulceration | Recommended |
| T4 | More than 4.0 mm | a = no ulceration, b = ulceration | Recommended |
In clinical practice
- Every patient with melanoma should be managed with a dermatology, surgery and oncology team; in Colombia this is arranged through the patient's insurer (EPS) with a cancer centre.
- Follow-up is more frequent in the first years (when most recurrences occur) and in higher stages, then at least yearly for life; there is no single correct schedule.
- At each visit: full-skin examination for new primaries, inspection of the scar and the skin up to the nodes for in-transit lesions, palpation of the nodes, and questions about new symptoms.
- Self-examination is the backbone of follow-up: a monthly check of the whole skin with a mirror or a partner, including scalp, soles and nails, and self-palpation of the scar and node areas.
- Sun protection continues, and first-degree relatives are offered a skin check.
Next step
- Insist on a pathology report with Breslow thickness, ulceration, mitotic rate and margins; ask for review if any item is missing.
- Sentinel node biopsy from T1b upwards after discussion; nodal ultrasound for selected patients and those who decline it.
- Imaging (CT, PET-CT, brain MRI) and LDH for stage IIB and above or for symptoms, not for thin, asymptomatic melanoma.
- BRAF mutation testing of the tumour in stage III and IV disease, to guide systemic therapy.
- Refer every new melanoma to a skin cancer team (dermatology, surgical oncology, oncology) for staging and treatment decisions.
Common traps
- A wide excision is the right first operation for a suspected melanoma: remove it whole with a narrow margin first, so depth is measured and the lymphatic map for the sentinel node is kept.
- Clark level is still the key measure of depth: the AJCC 8th edition stages by Breslow thickness and ulceration; Clark level is no longer used for T staging.
- A negative sentinel node means no follow-up is needed: it lowers the risk, but recurrences and second primary melanomas still occur; checks continue for life.
- Every patient with melanoma needs CT scans: in thin, asymptomatic melanoma imaging finds more false alarms than metastases; it is for stage IIB and above or symptoms.
- A small melanoma is a thin melanoma: depth, not diameter, predicts outcome; a small nodular melanoma can be thick.
Test yourself
Think of the answer, then tap the question to see it.
A melanoma is reported as 0.6 mm thick with ulceration. What is its T category and what does it change?
T1b, because ulceration upgrades it; sentinel lymph node biopsy is now discussed with the patient.
Why should a suspected melanoma not be removed first with a wide margin?
The first step is a narrow excision to measure Breslow depth; a wide excision first can disrupt the lymphatic drainage used to find the sentinel node.
A patient treated for a 0.5 mm melanoma asks if she needs CT scans every year. What do you answer?
No: for thin, asymptomatic melanoma routine imaging does not help; regular skin and node checks and monthly self-examination do.
Elsewhere in DurgiPedia
Connections
See it in 3D1
The structures of Durgical's 3D anatomy where it is found.
In Pharmacology6
Educational content; it does not replace assessment by a doctor or dermatologist and is not a clinical instruction. For a rash with fever, painful skin, blisters or peeling, sores in the mouth or eyes, or a swelling throat, go to an emergency department at once.
Sources: Cutaneous Melanoma: Guideline-Based Management and Interprofessional Collaboration (StatPearls Publishing (NCBI Bookshelf), 2024); Mohs Micrographic Surgery Guidelines of Care and Staging Systems for Melanoma (StatPearls Publishing (NCBI Bookshelf), 2024); Melanoma Treatment (PDQ), Health Professional Version (National Cancer Institute, 2024); Melanoma (MedlinePlus (U.S. National Library of Medicine), 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
